178.51
前日終値:
$183.63
開ける:
$182.49
24時間の取引高:
1.10M
Relative Volume:
0.25
時価総額:
$126.35B
収益:
$24.78B
当期純損益:
$3.68B
株価収益率:
34.50
EPS:
5.1743
ネットキャッシュフロー:
$5.29B
1週間 パフォーマンス:
-4.39%
1か月 パフォーマンス:
+7.17%
6か月 パフォーマンス:
-23.20%
1年 パフォーマンス:
-12.83%
Danaher Corp Stock (DHR) Company Profile
名前
Danaher Corp
セクター
電話
(202) 828-0850
住所
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR vs TMO, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
DHR
Danaher Corp
|
178.51 | 129.97B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
TMO
Thermo Fisher Scientific Inc
|
467.71 | 179.14B | 45.20B | 6.87B | 6.75B | 18.19 |
|
IDXX
Idexx Laboratories Inc
|
557.17 | 43.93B | 4.45B | 1.10B | 1.06B | 13.59 |
|
A
Agilent Technologies Inc
|
128.01 | 37.17B | 7.23B | 1.41B | 1.09B | 4.979 |
|
WAT
Waters Corp
|
355.86 | 35.66B | 3.77B | 449.25M | 240.68M | 7.8556 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-09 | 開始されました | Goldman | Buy |
| 2025-12-02 | 開始されました | Morgan Stanley | Overweight |
| 2025-10-08 | ダウングレード | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-11 | アップグレード | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | アップグレード | Barclays | Equal Weight → Overweight |
| 2025-03-21 | アップグレード | Goldman | Neutral → Buy |
| 2025-03-14 | アップグレード | Stifel | Hold → Buy |
| 2025-02-03 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | 開始されました | Scotiabank | Sector Perform |
| 2024-12-19 | 開始されました | Guggenheim | Buy |
| 2024-12-13 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-10-31 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | 開始されました | Stephens | Overweight |
| 2024-08-28 | 開始されました | Wells Fargo | Equal Weight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-17 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-01-24 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2023-12-18 | 開始されました | HSBC Securities | Hold |
| 2023-12-13 | 再開されました | Wolfe Research | Peer Perform |
| 2023-12-07 | ダウングレード | Goldman | Buy → Neutral |
| 2023-07-19 | 開始されました | Raymond James | Outperform |
| 2023-05-01 | 開始されました | SVB Securities | Outperform |
| 2023-04-26 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-04-18 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-10-24 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-08-17 | 再開されました | Bernstein | Outperform |
| 2022-07-20 | 開始されました | UBS | Buy |
| 2022-06-01 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | 開始されました | Bernstein | Outperform |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-09-10 | 繰り返されました | BofA Securities | Buy |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-23 | 繰り返されました | Goldman | Buy |
| 2021-07-16 | 開始されました | The Benchmark Company | Buy |
| 2021-04-07 | 再開されました | Robert W. Baird | Outperform |
| 2021-03-03 | 再開されました | Barclays | Overweight |
| 2020-12-02 | 開始されました | Goldman | Buy |
| 2020-11-25 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | 繰り返されました | Needham | Buy |
| 2020-01-08 | 開始されました | Wells Fargo | Overweight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-11-15 | 再開されました | Stifel | Hold |
| 2019-10-28 | 繰り返されました | Needham | Buy |
| 2019-10-14 | 再開されました | Credit Suisse | Outperform |
| 2019-07-19 | 繰り返されました | Needham | Buy |
| 2019-06-11 | 開始されました | Piper Jaffray | Neutral |
| 2019-05-30 | 開始されました | Wolfe Research | Outperform |
| 2019-04-17 | 繰り返されました | Needham | Buy |
| 2019-02-28 | 繰り返されました | Needham | Buy |
| 2019-02-25 | アップグレード | Janney | Neutral → Buy |
| 2019-01-03 | 開始されました | Needham | Buy |
| 2018-04-20 | 繰り返されました | Stifel | Buy |
すべてを表示
Danaher Corp (DHR) 最新ニュース
Danaher Closes $9.9B Acquisition of Masimo - Medical Product Outsourcing
DHR Initiated Coverage On by Piper Sandler -- Price Target Annou - GuruFocus
Piper Sandler initiates Danaher stock coverage with neutral rating - Investing.com
Why Is Danaher Drawing Attention Among Bluestock Indices Trends? - Kalkine Media
Danaher Closes on Acquisition of Masimo - Orange County Business Journal
Danaher Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Danaher completes acquisition of Masimo, company delists from Nasdaq - Investing.com UK
Danaher completes acquisition of Masimo, company delists from Nasdaq By Investing.com - Investing.com Nigeria
Is Danaher stock underperforming the S&P 500? - MSN
Danaher (DHR) Completes Acquisition of Masimo, Expanding Diagnos - GuruFocus
Danaher Completes Acquisition of Masimo, Expanding Acute Care Diagnostics Platform - citybiz
Danaher completes $10B acquisition of Masimo - MassDevice
Masimo Pays Off and Terminates 2025 Credit Agreement as Danaher Merger Closes - TradingView
Danaher completes acquisition of Masimo Corporation - Investing.com
Danaher completes acquisition of Masimo Corporation By Investing.com - Investing.com Canada
Danaher Completes Acquisition of Masimo Corporation - Yahoo Finance
Danaher Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Wolfe Research Downgrades Danaher Corporation (DHR) - Insider Monkey
Danaher (DHR) Moves Towards Acquisition of Masimo (MASI) - GuruFocus
SIRI Stock Surges 5% After-Hours On S&P MidCap 400 Inclusion - TradingView
As Danaher nears Masimo deal, Sirius XM moves into S&P index - Stock Titan
Danaher Corp. stock (US2358511028): Diagnostics and life science group after recent earnings in focu - AD HOC NEWS
Phenomenex Introduces Luna Omega HILIC LC Columns to Increase Sensitivity and Consistency in Polar Compound Analysis - PR Newswire
Why Wall Street Sees Danaher (DHR) Benefiting From Improving Industry Conditions - Yahoo Finance
Top 5 Stocks That Members of Congress Own - Insider Monkey
Danaher Insiders Sold US$235m Of Shares Suggesting Hesitancy - Yahoo Finance
Dominion Energy Inc stock (US2358511028): shares ease while investors weigh earnings and sector outl - AD HOC NEWS
Danaher Corp. stock outperforms competitors despite losses on the day - MarketWatch
Chemiluminescence Immunoassay Market Expected to Reach USD 16.39 Billion by 2031 | MarketsandMarkets™ - GlobeNewswire Inc.
DHR Stock Chart | DANAHER CORP (NYSE:DHR) - ChartMill
CIBC Atlas Income Opportunities Fund's Danaher Corp(DHR) Holding History - GuruFocus
Is It Too Late to Buy Danaher Corp (DHR) After 4.8% Rally? GF Va - GuruFocus
Danaher Corp. stock outperforms competitors on strong trading day - MarketWatch
Danaher jumps as investors focus on fresh financing steps and Masimo deal progress - Quiver Quantitative
IDBS i3 2026 forum in Boston showcases real-world customer outcomes in data-driven BioPharma - Yahoo Finance
Masimo Stock Is Stuck Just Below Danaher’s $180 Bid. The Gap Is the Story - Bez Kabli
Jim Cramer on Danaher: “At These Prices, It’s Clearly Overvalued” - Insider Monkey
Danaher’s vision for smarter infectious disease testingSelectScience interview - Select Science
Danaher (NYSE: DHR) issues long-dated CHF senior notes for general purposes - Stock Titan
Leica Biosystems Announces Expansion of Collaboration to Scale Precision Medicine and Develop AI-Powered Diagnostics - PR Newswire
DHR Assumed by Wolfe Research -- Rating Set to Peer Perform - GuruFocus
Here are Tuesday’s top Wall Street analyst research calls: CoreWeave, Danaher, Hewlett Packard Enterprise, Intuit, Knight-Swift, Meta Platforms, Starwood Property Trust, Tripadvisor, and more - MSN
What Danaher (DHR)'s New AI-Enabled SCIEX Mass Spec Platform Means For Shareholders - simplywall.st
Is It Time To Reassess Danaher (DHR) After Its Recent Share Price Weakness? - Yahoo Finance
Danaher Corp. stock (US2358511028): Wolfe Research starts coverage as shares trade lower - AD HOC NEWS
Here Are Tuesday’s Top Wall Street Analyst Research Calls: CoreWeave, Danaher, Hewlett Packard Enterprise, Intuit, Knight-Swift, Meta Platforms, Starwood Property Trust, Tripadvisor, and More - Yahoo Finance
Danaher Corp. May Be the Smartest Bet in Biotech Right Now - AOL.com
DoorDash Inc stock (US2358511028): shares advance as earnings momentum and US food delivery demand s - AD HOC NEWS
Wolfe Research initiates Danaher stock coverage with Peerperform rating By Investing.com - Investing.com South Africa
Wolfe Research initiates Danaher stock coverage with Peerperform rating - Investing.com
Danaher Corp. stock (US2358511028): shares ease while investors digest product updates and analyst b - AD HOC NEWS
Danaher Corp (DHR) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):